Insider Transactions in Q3 2023 at Reata Pharmaceuticals Inc (RETA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2023
|
Antal Rohit Desai |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,928,368
-100.0%
|
-
|
|
Sep 26
2023
|
R Kent Mc Gaughy Jr |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,901,772
-100.0%
|
-
|
|
Sep 26
2023
|
R Kent Mc Gaughy Jr |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,004
-100.0%
|
-
|
|
Sep 26
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,089
-100.0%
|
-
|
|
Sep 26
2023
|
William D. Mc Clellan Jr. Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,017
-100.0%
|
-
|
|
Sep 26
2023
|
Martin Edwards Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,116
-100.0%
|
-
|
|
Sep 26
2023
|
James Warren Huff Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,398
-100.0%
|
-
|
|
Sep 26
2023
|
James Warren Huff Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
122,480
-100.0%
|
-
|
|
Sep 26
2023
|
Steven Ryder Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,907
-100.0%
|
-
|
|
Sep 26
2023
|
Rajiv Patni EVP, Chief R&D Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
45,000
-100.0%
|
-
|
|
Sep 26
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,805
-100.0%
|
-
|
|
Sep 26
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
81,633
-100.0%
|
-
|
|
Sep 26
2023
|
Shamim Ruff Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,359
-100.0%
|
-
|
|
Sep 26
2023
|
William Rose Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
568,170
-100.0%
|
-
|
|
Sep 26
2023
|
William Rose Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,413
-100.0%
|
-
|
|
Sep 26
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,621
-100.0%
|
-
|
|
Sep 26
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,416
-100.0%
|
-
|
|
Sep 26
2023
|
Christy J. Oliger Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,565
-100.0%
|
-
|
|
Sep 26
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
49,701
-100.0%
|
-
|
|
Sep 14
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
3,175
-10.05%
|
$546,100
$172.03 P/Share
|
|
Sep 05
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
406
-1.66%
|
$68,614
$169.2 P/Share
|
|
Aug 23
2023
|
William Rose Director |
SELL
Bona fide gift
|
Indirect |
500,000
-56.86%
|
-
|
|
Aug 16
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
398
-0.79%
|
$66,864
$168.76 P/Share
|
|
Aug 16
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
596
-0.72%
|
$100,128
$168.74 P/Share
|
|
Aug 16
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
1,755
-2.73%
|
$294,840
$168.41 P/Share
|
|
Aug 16
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
398
-1.16%
|
$66,864
$168.33 P/Share
|
|
Aug 16
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
210
-0.85%
|
$35,280
$168.42 P/Share
|
|
Aug 15
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
807
-1.59%
|
$136,383
$169.04 P/Share
|
|
Aug 15
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
2,144
-2.54%
|
$362,336
$169.07 P/Share
|
|
Aug 15
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
807
-2.31%
|
$136,383
$169.04 P/Share
|
|
Aug 15
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
193
-0.78%
|
$32,617
$169.06 P/Share
|
|
Jul 28
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
75,000
-53.81%
|
$12,300,000
$164.62 P/Share
|
|
Jul 28
2023
|
Manmeet Singh Soni COO, CFO and President |
BUY
Conversion of derivative security
|
Direct |
75,000
+34.99%
|
-
|
|
Jul 28
2023
|
Shamim Ruff Director |
SELL
Open market or private sale
|
Direct |
8,235
-52.81%
|
$1,350,540
$164.53 P/Share
|
|
Jul 28
2023
|
Shamim Ruff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,235
+15.02%
|
$757,620
$92.2 P/Share
|
|
Jul 28
2023
|
William D. Mc Clellan Jr. Director |
SELL
Open market or private sale
|
Direct |
5,000
-45.38%
|
$820,000
$164.49 P/Share
|
|
Jul 28
2023
|
William D. Mc Clellan Jr. Director |
BUY
Conversion of derivative security
|
Direct |
5,000
+31.22%
|
-
|
|
Jul 28
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
40,000
-53.33%
|
$6,560,000
$164.54 P/Share
|
|
Jul 28
2023
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Conversion of derivative security
|
Direct |
40,000
+34.78%
|
-
|
|
Jul 06
2023
|
Colin John Meyer Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+6.64%
|
-
|
|
Jul 06
2023
|
Manmeet Singh Soni COO, CFO and President |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+8.53%
|
-
|
|
Jul 06
2023
|
Michael D Wortley Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,125
+7.5%
|
-
|
|
Jul 06
2023
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,125
+10.54%
|
-
|
|
Jul 06
2023
|
James Warren Huff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,220
+28.07%
|
-
|